COM:THORNE
Thorne HealthTech
- Stock
Last Close
10.20
13/10 20:00
Market Cap
550.63M
Beta: -
Volume Today
84.69K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
---|---|---|---|---|---|
average inventory | 27.90M - | 34.54M 23.80% | 49.83M 44.27% | ||
average payables | 7.69M - | 12.79M 66.35% | 21.94M 71.56% | ||
average receivables | 3.73M - | 4.08M 9.37% | 10.04M 145.99% | ||
book value per share | -2.77 - | -1.82 34.29% | 4.31 336.58% | 2.75 36.29% | |
capex per share | -0.08 - | -0.05 33.95% | -0.18 249.72% | -0.34 83.81% | |
capex to depreciation | -0.63 - | -0.54 14.42% | -1.14 110.26% | -3.07 169.86% | |
capex to operating cash flow | 0.38 - | -0.14 135.62% | -0.56 310.44% | -3.42 513.93% | |
capex to revenue | -0.03 - | -0.02 40.79% | -0.03 62.90% | -0.08 185.81% | |
cash per share | 0.01 - | 0.35 2,619.53% | 1.86 437.23% | 0.68 63.28% | |
days of inventory on hand | 175.16 - | 139.06 20.61% | 170.32 22.48% | 188.10 10.44% | |
days payables outstanding | 42.23 - | 43.06 1.96% | 70.14 62.88% | 86.59 23.46% | |
days sales outstanding | 17.63 - | 6.63 62.40% | 11.14 68.00% | 23.04 106.87% | |
debt to assets | 0.40 - | 0.44 10.56% | 0.19 57.99% | 0.20 9.68% | |
debt to equity | -0.40 - | -0.64 58.93% | 0.28 143.24% | 0.32 17.54% | |
dividend yield | 0.01 - | ||||
earnings yield | -0.06 - | -0.01 87.83% | 0.06 938.76% | 0.08 32.90% | |
enterprise value | 315.14M - | 368.92M 17.07% | 152.25M 58.73% | 202.52M 33.02% | |
enterprise value over ebitda | -32.96 - | 72.82 320.95% | 9.71 86.67% | 19.65 102.39% | |
ev to operating cash flow | -41.35 - | 21.57 152.15% | 16.76 22.28% | 38.78 131.40% | |
ev to sales | 3.07 - | 2.66 13.31% | 0.82 69.15% | 0.89 7.73% | |
free cash flow per share | -0.29 - | 0.34 216.05% | 0.15 56.34% | -0.24 263.66% | |
free cash flow yield | -0.04 - | 0.04 216.05% | 0.02 46.92% | -0.07 379.97% | |
graham net net | -5.21 - | -3.88 25.53% | 0.69 117.70% | -0.13 119.25% | |
graham number | 5.33 - | 1.51 71.72% | 6.09 304.00% | 4.29 29.65% | |
income quality | 0.42 - | -4.33 1,134.20% | 1.33 130.67% | 0.35 73.65% | |
intangibles to total assets | 0.23 - | 0.19 16.10% | 0.12 37.23% | 0.14 15.59% | |
interest coverage | -34.22 - | 0.68 102.00% | 21.68 3,065.76% | 208.19 860.48% | |
interest debt per share | 1.13 - | 1.19 5.67% | 1.21 1.49% | 0.89 26.09% | |
inventory turnover | 2.08 - | 2.62 25.96% | 2.14 18.35% | 1.94 9.45% | |
invested capital | -0.40 - | -0.64 58.93% | 0.28 143.24% | 0.32 17.54% | |
market cap | 275.02M - | 332.88M 21.04% | 170.64M 48.74% | 191.51M 12.23% | |
net current asset value | -174.01M - | -155.60M 10.58% | 44.29M 128.47% | 33.47M 24.44% | |
net debt to ebitda | -4.20 - | 7.11 269.55% | -1.17 116.48% | 1.07 191.10% | |
net income per share | -0.46 - | -0.06 87.83% | 0.38 789.90% | 0.30 22.32% | |
operating cash flow per share | -0.21 - | 0.39 285.46% | 0.33 14.80% | 0.10 70.06% | |
payables turnover | 8.64 - | 8.48 1.93% | 5.20 38.60% | 4.22 19.00% | |
receivables turnover | 20.70 - | 55.06 165.96% | 32.78 40.48% | 15.84 51.66% | |
research and ddevelopement to revenue | 0.04 - | 0.03 19.75% | 0.03 5.00% | 0.03 1.30% | |
return on tangible assets | -0.21 - | -0.03 87.70% | 0.07 360.36% | 0.08 16.25% | |
revenue per share | 2.81 - | 3.14 11.56% | 6.74 114.68% | 4.34 35.69% | |
roe | 0.16 - | 0.03 81.48% | 0.09 191.61% | 0.11 21.93% | |
roic | 0.43 - | 0.54 26.66% | 0.05 90.53% | 0.05 8.30% | |
sales general and administrative to revenue | 0.30 - | 0.33 11.48% | |||
shareholders equity per share | -2.77 - | -1.82 34.29% | 4.31 336.58% | 2.75 36.29% | |
stock based compensation to revenue | 0.12 - | 0.07 39.20% | 0.02 66.09% | 0.05 101.59% | |
tangible asset value | -129.93M - | -108.91M 16.18% | 97.30M 189.34% | 114.78M 17.97% | |
tangible book value per share | -3.57 - | -2.47 30.75% | 3.54 243.35% | 2.18 38.56% | |
working capital | 1.38M - | 30.65M 2,123.11% | 75.52M 146.41% | 77.06M 2.04% |
All numbers in USD (except ratios and percentages)